Malassezia and acne: why fungal findings do not establish fungal acne

Distinguishing acne vulgaris from Malassezia folliculitis helps patients receive care directed at the condition they actually have. Malassezia yeasts normally live on skin; they can also cause a symptomatic folliculitis that resembles or coexists with acne. Clinical examination, the lesion pattern and appropriate testing are more useful than labelling an eruption “fungal acne” from yeast detection alone.^{2, 3, 4}

Research into fungi in ordinary acne is developing. A 2026 review found Malassezia on both healthy and acne-prone skin, without a robust fungal signature specific to acne. This leaves a possible contribution open while keeping the evidence for folliculitis separate from the evidence for acne vulgaris.¹

Key messages

• Normal yeast residency, acne-associated fungal findings and symptomatic folliculitis are different observations.^{1, 2, 4}

• Similar-looking follicular papules and pustules, often with itch and without comedones, should prompt consideration of Malassezia folliculitis.^{4, 5}

• Fungal-community findings vary with the skin site and sampling method; they do not yet establish a universal acne signature.^{1, 9, 10}

• Antifungals can treat confirmed folliculitis. That evidence does not establish a routine antifungal treatment for ordinary acne.^{2, 4, 7}

What is the difference between normal yeast residency and folliculitis?

The skin mycobiome is the fungal part of its microbial community. Malassezia yeasts are normal residents, particularly in oily areas. Their presence on healthy and acne-prone skin means that a positive finding needs clinical context.^{1, 4}

Malassezia folliculitis is a symptomatic inflammation of hair follicles associated with these yeasts. Acne vulgaris involves several interacting processes, including sebum production, follicular blockage, microbial activity and inflammation. Finding the same organism in an acne lesion does not by itself establish a fungal cause.^{1, 2}

It is useful to distinguish detection, association, a plausible mechanism and demonstrated clinical causation. The current evidence supports further investigation of fungi in acne, while clinical recognition of folliculitis already has a practical role.^{1, 2}

Which clinical patterns should prompt a closer look?

Look at the eruption as a whole: lesion types, symptoms, affected sites and recent exposures. Acne and Malassezia folliculitis can occur together, so comedones in one area do not explain every follicular eruption elsewhere.^{3, 5}

Scroll horizontally to view the full table.

These are clinical clues rather than a diagnostic score. Itch or uniformity alone does not confirm folliculitis, and absent itch does not exclude it. Ask about corticosteroids, antibiotics, sweating and occlusion without turning a risk association into a blanket prohibition on moisturisers or sunscreens.^{4, 5, 6}

In a Bangkok clinic study during the rainy season, 320 new patients initially diagnosed with acne underwent lesion sampling and microscopy. Under the study’s criteria, 24.7% had both acne and Malassezia folliculitis and 4.1% had folliculitis alone, giving 28.8% with folliculitis. These findings support considering coexistence in a suitable presentation; they are not a universal prevalence estimate.³

What can examination and testing clarify?

Examination helps distinguish acne vulgaris, Malassezia folliculitis, bacterial folliculitis and steroid-related acneiform eruptions. When uncertainty remains, microscopy of appropriately sampled material can support the assessment.^{4, 7}

A potassium hydroxide preparation can reveal budding yeasts. Hyphae, the filamentous form of fungi, are rarely seen in this condition and are not required for diagnosis. Histopathology can show yeast within the follicle, which provides different information from a surface finding. Culture usually needs special media and is not routinely performed in every case.^{4, 7}

Dermoscopy, examination with a magnifying skin instrument, and Wood lamp examination may add supportive findings. Yellow-green fluorescence under a Wood lamp is not specific to a fungal genus or species, and neither tool replaces the full clinical assessment.⁵

The European Academy of Dermatology and Venereology (EADV) position statement addresses positive diagnostic findings before therapy and management for different patient groups. Use the complete recommendations and clinical context for prescribing decisions; the retained abstract alone does not provide the full algorithm.²

What do studies show on facial and truncal skin?

The available studies describe fungal ecology, which is the pattern of organisms in a skin environment. The comparison below separates the broad review from selected observational studies; it is not a pooled treatment-effect analysis.

Internal transcribed spacer 1 and 2 (ITS1 and ITS2) are different regions of fungal ribosomal DNA used for sequencing.

Scroll horizontally to view the full table.

Malassezia restricta and Malassezia globosa are often identified on healthy and acne-prone facial skin. On the trunk, the studies reported different richness, diversity and species patterns. Richness counts the different types of fungi detected; diversity also reflects how a community is distributed or related. A finding of no significant difference does not prove that two communities are identical.^{1, 9, 10}

Their findings provide complementary perspectives, not interchangeable measurements or automatic independent replication. Skin swabs, extracted follicular material and different culture media also sample or recover organisms differently.^{1, 9, 10}

Keep the anatomical setting visible. Truncal skin is a different niche from the face, so findings from upper-back samples should not be transferred directly to facial acne.^{1, 9, 10}

How might fungi interact with the follicular environment?

Malassezia can break down sebum lipids and generate products that may influence irritation or inflammatory signalling. Researchers also propose interactions between fungi and bacteria such as Cutibacterium acnes and Staphylococcus. These ideas help frame testable questions about the follicular environment.¹

Much of the mechanistic evidence comes from cell experiments or other disease models. It does not quantify how much fungi contribute to an individual’s acne or demonstrate that targeting a named pathway improves clinical acne. Fungal-only sequencing likewise does not directly measure bacterial–fungal interactions.^{1, 9}

When is antifungal treatment relevant?

Antifungal treatment is directly relevant to Malassezia folliculitis. Condition-specific references describe topical options, including ketoconazole, and oral therapy for selected patients. The EADV statement distinguishes management considerations for immunocompetent and immunocompromised people and for those with compromised liver function.^{2, 4}

Choose treatment through an appropriate diagnostic and prescribing assessment. Oral treatment has not consistently been shown to be more effective than topical treatment, and recurrence can occur. Predisposing factors and individual maintenance needs may warrant review; comparative evidence does not establish one universal maintenance schedule.^{4, 5, 7}

If an eruption previously called acne improves with an antifungal, reassess which lesions changed. Missed or coexisting folliculitis is one explanation. Similarly, persistent uniform follicular bumps despite acne treatment should prompt diagnostic reconsideration, rather than being treated as confirmation of a fungal diagnosis.^{3, 5}

When both conditions are present, the care plan should address both. Yeast detection alone is not a reason to replace otherwise indicated acne treatment.^{2, 3, 5}

How should antibiotic exposure be interpreted?

Antibiotic exposure is a recognised contextual risk factor for Malassezia folliculitis. It is useful information in the history, but does not predict an inevitable yeast bloom or symptomatic folliculitis.⁴

The two truncal sequencing reports found heterogeneous doxycycline-associated species patterns and persistent Malassezia dominance, without uniform convergence towards healthy controls. In the ITS2 report, only two participants had sufficient repeated sampling for true within-person analysis; the ITS1 report used paired comparisons but described variable follow-up and unmeasured contextual factors.^{9, 10}

These results describe treatment-associated ecology. They do not show that doxycycline caused folliculitis or that fungal changes were responsible for acne improvement or deterioration. Review clinical symptoms and treatment need alongside the microbial measurements.^{9, 10}

How can the distinction be explained in practice?

A useful explanation is: “This yeast normally lives on skin. It can cause a separate folliculitis that looks like acne, but finding it does not tell us that your acne is fungal.” Then discuss the lesion pattern, symptoms, sites and any need for testing.^{1, 2, 4}

For general practitioners, pharmacists, nurses and trainees, persistent or uncertain eruptions merit appropriate examination rather than an escalating search for “fungal-acne-safe” ingredients. Dermatologists can use the same history to assess acne, folliculitis, coexistence and other acneiform conditions.⁵

When interpreting a claim, identify what was studied: normal colonisation, acne-associated ecology, a laboratory mechanism or confirmed folliculitis. Check whether the outcome was a microbial measurement or a clinical treatment effect. Evidence that fungi cause folliculitis cannot be carried over automatically to ordinary acne.^{1, 2}

For broader background, the L’Oréal Dermatological Beauty Pro resource on acne microbiology from phyla to phylotypes introduces the wider microbial context. It is not evidence of antifungal efficacy in acne.

References

1. Kerob D, Salah S, Dal Belo SE, Odeimi J, Clavaud C, Demessant-Flavigny AL. A Possible Role of Mycobiome in the Pathophysiology of Acne: Structured Narrative Review and Perspectives. Experimental Dermatology. 2026. View source ↗
2. pubmed.ncbi.nlm.nih.gov. Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis [Internet]. Accessed 3 November 2026. View source ↗
3. dovepress.com. Malassezia folliculitis in patients with acne vulgaris [Internet]. Accessed 3 November 2026. View source ↗
4. dermnetnz.org. Malassezia (pityrosporum) folliculitis [Internet]. Accessed 3 November 2026. View source ↗
5. pmc.ncbi.nlm.nih.gov. Malassezia Folliculitis: An Underdiagnosed Mimicker of Acneiform Eruptions [Internet]. Accessed 3 November 2026. View source ↗
6. dermatologytimes.com. Malassezia Folliculitis vs Acne Vulgaris: Key Diagnostic and Treatment Differences [Internet]. Accessed 3 November 2026. View source ↗
7. pubmed.ncbi.nlm.nih.gov. Critical synthesis of available data in Malassezia folliculitis and a systematic review of treatments [Internet]. Accessed 3 November 2026. View source ↗
8. pubmed.ncbi.nlm.nih.gov. Microorganisms inhabiting follicular contents of facial acne are not only Propionibacterium but also Malassezia spp [Internet]. Accessed 3 November 2026. View source ↗
9. pubmed.ncbi.nlm.nih.gov. Ecological characteristics of the truncal skin mycobiome in acne and its association with doxycycline exposure [Internet]. Accessed 3 November 2026. View source ↗
10. pubmed.ncbi.nlm.nih.gov. ITS1-based profiling of the skin mycobiome in truncal acne reveals altered baseline ecology and heterogeneous doxycycline-associated patterns [Internet]. Accessed 3 November 2026. View source ↗

Review note. The 2026 structured narrative review synthesised heterogeneous, mainly small cross-sectional studies. It was funded by La Roche-Posay; four authors were La Roche-Posay employees and two were L’Oréal Research and Innovation employees. Laboratory and other-disease findings inform hypotheses rather than establish clinical causation in acne.¹